Human antibodies to GFRα3 and methods of making thereof
US10947312B2 · kind B2 · utility
0Cited by
10References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2019 |
| Grant date | Mar 16, 2021 |
| Priority date | — |
| Expiry date | Aug 15, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides antibodies that bind to human GFRα3 and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human GFRα3. The antibodies of the invention are useful for the treatment of diseases and disorders associated with one or more GFRα3 biological activities, including the treatment of acute or chronic pain conditions, or inflammatory conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.